Compare Abeona Therapeutics Inc (ABEO) vs iShares Core S&P 500 ETF (IVV) Price & Performance

Abeona Therapeutics IncTrade

iShares Core S&P 500 ETFTrade

Price performance (Past 24H)

Key statistics

Abeona Therapeutics Inc vs iShares Core S&P 500 ETF — how do they compare? Abeona Therapeutics Inc trades at $7.37 (market cap $421.19M), while iShares Core S&P 500 ETF trades at $775.98. Which is the better fit depends on your goals.

	ABEO	IVV
Market Cap	$421.19M	—
Sector	Health	Broad Market / Factor
52-Week High	$7.45	$776.81
52-Week Low	$4.17	$634.93
Enterprise Value	$276.10M	—

View details →View details →

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

ABEO

View details →

IVV

WisdomTree U.S. Total Dividend ETF (DTD) rated 'hold' for balanced factors but overlaps 57% with S&P 500 ETFs.Seeking Alpha · 1 day agoNeutral Main Sector Rotation ETF (SECT) gets Hold rating due to weak performance versus IVV.Seeking Alpha · 4 days agoNeutral View details →

About Abeona Therapeutics Inc

Abeona Therapeutics develops gene and cell therapies for rare diseases. Its lead product, ZEVASKYN, is an FDA-approved therapy for recessive dystrophic epidermolysis bullosa (RDEB), a severe and life-threatening genetic skin disorder.

About iShares Core S&P 500 ETF

IVV tracks the performance of the S&P 500 Index, offering low-cost exposure to 500 of the largest US companies. It is a cornerstone for long-term investors seeking broad growth in the US stock market.